ASML vs BRTX · P/E 57, $665.37B cap vs rev $401.0K
ASML Holding NV ADR (ASML) versus BioRestorative Therapies Inc (BRTX) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
ASML does not have a complete income-statement cache yet.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. BRTX currently screens at market cap $10.2M.
Not investment advice. Open the ASML and BRTX stock pages for the full models.
Not investment advice.